Varicella zoster virus-Induced Pain in a Rat Model of Post-Herpetic Neuralgia

带状疱疹病毒引起的带状疱疹后神经痛大鼠模型疼痛

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Post-Herpetic Neuralgia (PHN) is a common, exceedingly painful and debilitating complication of Herpes Zoster that is difficult to treat and i unmet in the need for improved therapies. Zoster and PHN occur when varicella-zoster virus (VZV) reactivates from a latent state that was established in host sensory neurons during chickenpox. Most adults worldwide are at risk for Zoster, PHN and pain, which may be so severe as to profoundly reduce quality of life. Incidence increases with age, and our aging society implies Zoster and PHN may become even more pressing public health concerns. The mechanisms by which VZV causes persistent pain are not understood. This project, directed to FOA PA-13-118, expands a clinically relevant model of PHN in which VZV inoculated into the rat footpad induces prolonged mechanical allodynia and thermal hyperalgesia. Our overlying hypothesis is that this model will provide better comprehension of how VZV interacts with the nervous system to induce pain, and be a platform to test improved approaches for treatment of VZV-induced pain. Aim 1 will define the requirements of VZV expression and replication in the rat to induce pain. We will test the hypothesis that limited VZV expression is sufficient to drive chronic indicators of pain in the absence of productive replication. We will also test the hypothesis that VZV lacking the ORF47 kinase, which does not induce chronic pain, cannot initiate infection of the rat required for pain. Third, we will address the intrinsic properties by which the VZV IE62 transcriptional regulator induces chronic pain behaviors independent of other VZV proteins. These studies will establish the key components of VZV replication and expression in driving the pain state in the model. Aim 2 will focus on the role of infected neurons in contributing to the pain state. We will test the hypothesis that VZV protein expressing neurons directly drive nocifensive behaviors, exploiting an innovative ligand-dependent, neuron- specific pain repression system that involves expression of glycine receptors and activation by ligands. We will also address the neuron subtypes involved in driving a pain state that is induced by specific VZV pain-inducing proteins expressed from neuron-specific promoters in replication defective HSV (rdHSV) vectors. This could also establish a more prolonged model of VZV-induced pain behaviors. Aim 3 will address improved and more specific therapy of VZV-induced pain. We will test rdHSV expressing ligand-dependent glycine receptors for efficacy in blocking VZV induced pain signals in the rat following transcriptionally targeting of specific subpopulations of neurons. This will also reveal those neuron subtypes that transmit the VZV-induced pain signals. Together, these approaches have potential to revolutionize the way we think about how VZV induces pain and how we can more effectively provide relief to those unfortunate human patients suffering from PHN.
 描述(由申请人提供):带状疱疹后神经痛(PHN)是带状疱疹的一种常见、极度疼痛和使人衰弱的并发症,难以治疗,并且无法满足改善治疗的需求。水痘带状疱疹病毒(VZV)在水痘期间在宿主感觉神经元中建立的潜伏状态重新激活时发生带状疱疹和PHN。世界上大多数成年人都有患带状疱疹、PHN和疼痛的风险,这些风险可能非常严重,以至于严重降低生活质量。发病率随着年龄的增长而增加,我们的老龄化社会意味着带状疱疹和PHN可能成为更紧迫的公共卫生问题。VZV引起持续性疼痛的机制尚不清楚。该项目针对FOA PA-13-118,扩展了PHN的临床相关模型,其中VZV接种到大鼠足垫中诱导延长的机械异常性疼痛和热痛觉过敏。我们的假设是,该模型将提供更好的理解VZV如何与神经系统相互作用,以诱导疼痛,并成为一个平台,以测试VZV诱导的疼痛的治疗方法的改进。目的1明确VZV在大鼠体内表达和复制的条件,以诱导疼痛。我们将测试的假设,即有限的VZV表达是足以驱动慢性疼痛的指标,在没有生产性复制。我们还将检验缺乏ORF 47激酶的VZV不能引发疼痛所需的大鼠感染的假设,VZV不诱导慢性疼痛。第三,我们将通过以下方式解决固有属性: 其中VZV IE62转录调节因子诱导的慢性疼痛行为独立于其他VZV蛋白。这些研究将建立VZV复制和表达的关键组成部分,以驱动模型中的疼痛状态。Aim 2将关注受感染神经元的作用 对疼痛状态的影响。我们将测试表达VZV蛋白的神经元直接驱动伤害反应行为的假设,利用创新的配体依赖性神经元特异性疼痛抑制系统,其涉及甘氨酸受体的表达和配体的激活。我们还将讨论参与驱动疼痛状态的神经元亚型,该疼痛状态由复制缺陷型HSV(rdHSV)载体中神经元特异性启动子表达的特异性VZV疼痛诱导蛋白诱导。这也可以建立一个更长的模型VZV诱导的疼痛行为。目标3将解决VZV引起的疼痛的改进和更特异性的治疗。我们将测试rdHSV表达配体依赖性甘氨酸受体在大鼠中阻断VZV诱导的疼痛信号的功效,随后转录靶向特定的神经元亚群。这也将揭示那些传递VZV诱导的疼痛信号的神经元亚型。总之,这些方法有可能彻底改变我们对VZV如何引起疼痛的思考方式,以及我们如何更有效地为那些不幸的PHN患者提供救济。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul R. Kinchington其他文献

Paul R. Kinchington的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul R. Kinchington', 18)}}的其他基金

VZV vaccine attenuation and the DNA damage response
VZV 疫苗减毒和 DNA 损伤反应
  • 批准号:
    10657725
  • 财政年份:
    2022
  • 资助金额:
    $ 53.17万
  • 项目类别:
Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation
VZV 潜伏转录本 (VLT) 和 ORF63 在潜伏和重新激活中的作用
  • 批准号:
    10570901
  • 财政年份:
    2020
  • 资助金额:
    $ 53.17万
  • 项目类别:
Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivation
VZV 潜伏转录本 (VLT) 和 ORF63 在潜伏和重新激活中的作用
  • 批准号:
    10550430
  • 财政年份:
    2020
  • 资助金额:
    $ 53.17万
  • 项目类别:
Molecular studies of VZV infection, latency and reactivation in human neurons in-vitro
人类神经元水痘带状疱疹病毒感染、潜伏期和再激活的分子研究
  • 批准号:
    9179591
  • 财政年份:
    2015
  • 资助金额:
    $ 53.17万
  • 项目类别:
Molecular studies of VZV infection, latency and reactivation in human neurons in-vitro
人类神经元水痘带状疱疹病毒感染、潜伏期和再激活的分子研究
  • 批准号:
    9052861
  • 财政年份:
    2015
  • 资助金额:
    $ 53.17万
  • 项目类别:
A new in vitro neuron model of axonal transport and persistence of varicella zost
水痘带状疱疹轴突运输和持续性的新体外神经元模型
  • 批准号:
    8487903
  • 财政年份:
    2013
  • 资助金额:
    $ 53.17万
  • 项目类别:
A new in vitro neuron model of axonal transport and persistence of varicella zost
水痘带状疱疹轴突运输和持续性的新体外神经元模型
  • 批准号:
    8606907
  • 财政年份:
    2013
  • 资助金额:
    $ 53.17万
  • 项目类别:
Varicella zoster virus Induced Pain in a Rat Model of Post Herpetic Neuralgia
水痘带状疱疹病毒在带状疱疹后神经痛大鼠模型中引起疼痛
  • 批准号:
    9253247
  • 财政年份:
    2009
  • 资助金额:
    $ 53.17万
  • 项目类别:
Varicella zoster virus-Induced Pain in a Rat Model of Post-Herpetic Neuralgia
带状疱疹病毒引起的带状疱疹后神经痛大鼠模型疼痛
  • 批准号:
    7848656
  • 财政年份:
    2009
  • 资助金额:
    $ 53.17万
  • 项目类别:
Varicella zoster virus-Induced Pain in a Rat Model of Post-Herpetic Neuralgia
带状疱疹病毒引起的带状疱疹后神经痛大鼠模型疼痛
  • 批准号:
    7563123
  • 财政年份:
    2009
  • 资助金额:
    $ 53.17万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.17万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了